Your essential CDMO partner for Small Molecule APIs and Intermediates. We offer a complete range of services throughout the entire life cycle of API process development and manufacturing. We deliver comprehensive, agile, innovative solutions for your project, from clinical phase I to the commercial phase. Our commitment to the top pharma quality standards is reflected in all our processes.
Vision
Our vision is to be the first-choice small molecule CDMO.
To be the most trusted partner for our customers as a role model in this industry, we offer our Top Pharma Quality services, Supply Reliability, Agility, and Flexibility.
Mission
Our mission is to improve people’s lives by delivering our best quality products and services.
We are an essential part of the pharma industry and patient care.
Values
Customer Orientation
We work hard to understand our clients and satisfy their needs
Challenge
We challenge ourselves to bring better results and achieve our goals
Operational Excellence
We ensure that our activities and processes are carried out with the highest standards of excellence
Team Excellence
We cooperate for common goals by creating a positive, innovative and learning working environment
Flexibility
We quickly adapt our approach to successfully overcome new situations
Innovation
We generate new approaches and implement creative solutions and different ways of achieving goals
Who we are
1907
AGC founded in Japan
1917
AGC started production of chemical products
1957
Land acquisition by Boehringer Ingelheim
1959
Extraction Plant Construction
1960
S1 Construction
First batch of APIs manufactured
1967
S3 Construction
1974
S2 Construction
1997
Construction of Wastewater Treatment Plant
1998
Start of production 24×7
1999
First FDA (US) Approval
2001
Construction Development Laboratory / IPC
2003
Pilot Plant Construction
2006
Post Combustor Construction (Off-Gas Treatment Unit)
2009
First ISO 14001:2004
2010
First Protection Project
First OHSAS 18001:2007
First PMDA Inspection (Japan)
2013
Wastewater Treatment Plant Expansion
2019
Acquisition by AGC Group
2020
R&D Laboratory Expansion
EcoVadis First Assesment
2021
Micronization Plant Construction
First ISO 45001:2018
Last ISO 14001:2015
Electronic Batch Record Implementation
2022
The first phase of the manufacturing plant expansion
Launch of the Kilo Lab
Micronization fully operational
EcoVadis Platinum Medal
2023
Last FDA Inspection (US)
Last PMDA Inspection (Japan)
2024
Last Inspection AEMPS (Spain)
Pilot Plant Upgrade with HAPI
Our Locations
Explore our Europe and Japan sites to understand how our advanced facilities, labs, and integrated services support your projects. Discover more about our technologies through virtual site tours. For detailed support, contact our team.
